NYSE:HCA - HCA Healthcare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$131.57 +2.55 (+1.98 %)
(As of 08/20/2018 06:30 AM ET)
Previous Close$129.02
Today's Range$129.66 - $131.88
52-Week Range$71.18 - $131.88
Volume1.61 million shs
Average Volume1.97 million shs
Market Capitalization$44.35 billion
P/E Ratio19.97
Dividend Yield1.08%
Beta0.53
HCA Healthcare logoHCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of February 12, 2018, it owned and operated 179 hospitals and 120 freestanding surgery centers, and various other healthcare facilities in 20 states and the United Kingdom. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Receive HCA News and Ratings via Email

Sign-up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
SymbolNYSE:HCA
CUSIP40412C10
Phone615-344-9551

Debt

Debt-to-Equity Ratio-7.64
Current Ratio1.36
Quick Ratio1.15

Price-To-Earnings

Trailing P/E Ratio19.97
Forward P/E Ratio14.25
P/E Growth1.16

Sales & Book Value

Annual Sales$47.65 billion
Price / Sales0.96
Cash Flow$13.3845 per share
Price / Cash9.83
Book Value($14.11) per share
Price / Book-9.32

Profitability

EPS (Most Recent Fiscal Year)$6.59
Net Income$2.22 billion
Net Margins6.21%
Return on Equity-61.68%
Return on Assets7.79%

Miscellaneous

Employees253,000
Outstanding Shares346,050,000
Market Cap$44.35 billion

HCA Healthcare (NYSE:HCA) Frequently Asked Questions

What is HCA Healthcare's stock symbol?

HCA Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."

How often does HCA Healthcare pay dividends? What is the dividend yield for HCA Healthcare?

HCA Healthcare declared a quarterly dividend on Thursday, July 26th. Shareholders of record on Tuesday, September 4th will be paid a dividend of $0.35 per share on Friday, September 28th. This represents a $1.40 dividend on an annualized basis and a yield of 1.06%. The ex-dividend date is Friday, August 31st. View HCA Healthcare's Dividend History.

How were HCA Healthcare's earnings last quarter?

HCA Healthcare Inc (NYSE:HCA) released its earnings results on Wednesday, July, 25th. The company reported $2.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.16 by $0.13. The company had revenue of $11.53 billion for the quarter, compared to the consensus estimate of $11.32 billion. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The business's quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.73 earnings per share. View HCA Healthcare's Earnings History.

When is HCA Healthcare's next earnings date?

HCA Healthcare is scheduled to release their next quarterly earnings announcement on Tuesday, October, 30th 2018. View Earnings Estimates for HCA Healthcare.

What guidance has HCA Healthcare issued on next quarter's earnings?

HCA Healthcare issued an update on its FY18 earnings guidance on Wednesday, July, 25th. The company provided earnings per share guidance of $9.00-9.40 for the period, compared to the Thomson Reuters consensus estimate of $8.82. The company issued revenue guidance of $45.5-46.5 billion, compared to the consensus revenue estimate of $45.80 billion.

What price target have analysts set for HCA?

24 brokers have issued 12-month price targets for HCA Healthcare's shares. Their forecasts range from $81.00 to $151.00. On average, they anticipate HCA Healthcare's share price to reach $119.80 in the next twelve months. This suggests that the stock has a possible downside of 8.9%. View Analyst Price Targets for HCA Healthcare.

What is the consensus analysts' recommendation for HCA Healthcare?

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HCA Healthcare in the last year. There are currently 2 sell ratings, 6 hold ratings and 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for HCA Healthcare.

What are Wall Street analysts saying about HCA Healthcare stock?

Here are some recent quotes from research analysts about HCA Healthcare stock:
  • 1. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating and $115 price target, ahead of 2Q18 earnings, which is scheduled for Wednesday, 7/25/18. 1Q18 results featured stronger admissions, higher acuity and better rates, owing to its more complex services and urban setting and we believe that HCA remains the top name to own in the hospital group as it continues to outperform the industry. We expect continued strength going into 2Q18 (see our assumptions in Exhibit 3). There could be a slight M&A drag in 2Q18 due to lower initial margins from recent acquisitions, but we expect it to be temporary and the pickup in acquisitions should accelerate organic growth over the next three or four years, aided by the CMS proposal to boost acute care IPPS payments by 3.4% in 2019." (7/20/2018)
  • 2. According to Zacks Investment Research, "HCA Healthcare’s shares have outperformed the industry in a year’s time. Its top line has been growing over the last several quarters on strong volumes, and improved payor and service mix. A number of acquisitions helped the company to gain strong foothold in the industry. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 1.4% upward over the last 60 days. Its strong balance sheet is another positive while weakness in international operations is a concern. The company’s high valuation might keep the investors away." (7/16/2018)

Who are some of HCA Healthcare's key competitors?

Who are HCA Healthcare's key executives?

HCA Healthcare's management team includes the folowing people:
  • Mr. R. Milton Johnson, Chairman & CEO (Age 61)
  • Mr. Samuel N. Hazen, Pres & COO (Age 58)
  • Mr. William B. Rutherford, Exec. VP & CFO (Age 54)
  • Dr. Jonathan B. Perlin, Pres of Clinical Services & Chief Medical Officer (Age 57)
  • Mr. Charles J. Hall, Pres of National Group (Age 65)

Has HCA Healthcare been receiving favorable news coverage?

Media coverage about HCA stock has been trending somewhat positive on Monday, according to Accern. Accern ranks the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. HCA Healthcare earned a media and rumor sentiment score of 0.06 on Accern's scale. They also assigned news stories about the company an impact score of 47.38 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future. View Recent Headlines for HCA Healthcare.

Who are HCA Healthcare's major shareholders?

HCA Healthcare's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (6.22%), Magellan Asset Management Ltd (3.76%), Longview Partners Guernsey LTD (2.73%), FMR LLC (1.59%), LSV Asset Management (1.56%) and Bank of New York Mellon Corp (0.60%). Company insiders that own HCA Healthcare stock include A Bruce Moore Jr, Bill B Rutherford, Charles J Hall, Christopher F Wyatt, Deborah M Reiner, J William Morrow, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Joseph A Sowell III, Kathryn A Torres, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman, Samuel N Hazen, Sandra L Morgan, Thomas F Frist Jr and Victor L Campbell. View Institutional Ownership Trends for HCA Healthcare.

Which major investors are selling HCA Healthcare stock?

HCA stock was sold by a variety of institutional investors in the last quarter, including Magellan Asset Management Ltd, American Century Companies Inc., BlackRock Inc., Victory Capital Management Inc., Point72 Asset Management L.P., Orbimed Advisors LLC, Russell Investments Group Ltd. and Schroder Investment Management Group. Company insiders that have sold HCA Healthcare company stock in the last year include Bill B Rutherford, Charles J Hall, Deborah M Reiner, J William Morrow, Jane D Englebright, Jonathan B Perlin, Joseph A Sowell III, Kathryn A Torres, Michael S Cuffe, Ravi S Chari, Samuel N Hazen, Sandra L Morgan and Victor L Campbell. View Insider Buying and Selling for HCA Healthcare.

Which major investors are buying HCA Healthcare stock?

HCA stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, LSV Asset Management, Millennium Management LLC, Massachusetts Financial Services Co. MA, Canada Pension Plan Investment Board, Caisse DE Depot ET Placement DU Quebec and Martingale Asset Management L P. View Insider Buying and Selling for HCA Healthcare.

How do I buy shares of HCA Healthcare?

Shares of HCA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HCA Healthcare's stock price today?

One share of HCA stock can currently be purchased for approximately $131.57.

How big of a company is HCA Healthcare?

HCA Healthcare has a market capitalization of $44.35 billion and generates $47.65 billion in revenue each year. The company earns $2.22 billion in net income (profit) each year or $6.59 on an earnings per share basis. HCA Healthcare employs 253,000 workers across the globe.

How can I contact HCA Healthcare?

HCA Healthcare's mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company can be reached via phone at 615-344-9551 or via email at [email protected]


MarketBeat Community Rating for HCA Healthcare (NYSE HCA)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  862 (Vote Outperform)
Underperform Votes:  367 (Vote Underperform)
Total Votes:  1,229
MarketBeat's community ratings are surveys of what our community members think about HCA Healthcare and other stocks. Vote "Outperform" if you believe HCA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/20/2018 by MarketBeat.com Staff

Featured Article: Google Finance Portfolio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel